Two human-origin exosome products for professional skin rejuvenation workflows — ASCE+ SRLV and EXO MELA. Widely discussed in regenerative aesthetics literature, with transparent regulatory context.
Human-derived exosome products in aesthetics are typically formulated using exosomes isolated from human cell systems — most commonly stem cell conditioned media or similar platforms. This category is the most directly connected to the regenerative medicine and wound-healing exosome literature.
In dermatology and aesthetic practice, human-derived exosome products are positioned for skin rejuvenation contexts including skin quality support, hydration, pore appearance, firmness, and pigmentation-related concerns. They are used in standalone protocols and microneedling-related workflows.
The category has a broader preclinical and early clinical evidence base than plant-based equivalents, drawing on established wound healing and regenerative medicine literature — but this does not translate to regulatory approval or validated efficacy claims.
Human Cell Origin — Derived from human cell systems, typically stem cell conditioned media or related platforms.
Regenerative Medicine Foundation — Evidence base draws from wound healing, scar, and regenerative medicine exosome literature.
Careful Claims Required — Source type, concentration standardization, and regulatory classification require careful evaluation by professional buyers.
Korean Manufacturer Standards — Products manufactured under Korean MFDS frameworks for professional aesthetic use.
"Human-derived exosome products are positioned within the regenerative aesthetics landscape for skin rejuvenation contexts. The evidence base draws from wound healing and regenerative medicine literature — but the same literature warns against overstating efficacy, safety, or approval status."
Considering plant-based products? The plant-based skin rejuvenation range includes 5 products with botanical-origin formulations and different evidence positioning.